Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.
作者： Robert C. Shepard , Donna E. Levy , Jordan D. Berlin , Keith Stuart , Jules E. Harris
DOI: 10.1159/000078331
关键词:
摘要: Background: Responses have been observed in several studies of docetaxel as treatment for advanced pancreatic carcinoma. This trial was designed to determine if the addition doce
sci-hub.se 参考文章(10)
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff, R Nelson, F A Dorr, C D Stephens, D D Von Hoff, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology. ,vol. 15, pp. 2403- 2413 ,(1997) , 10.1200/JCO.1997.15.6.2403
William H. Sherman, Robert L. Fine, Combination Gemcitabine and Docetaxel Therapy in Advanced Adenocarcinoma of the Pancreas Oncology. ,vol. 60, pp. 316- 321 ,(2001) , 10.1159/000058527
David P. Ryan, Matthew H. Kulke, Charles S. Fuchs, Michael L. Grossbard, Steven R. Grossman, Jeffrey A. Morgan, Craig C. Earle, Ramesh Shivdasani, Haesook Kim, Robert J. Mayer, Jeffrey W. Clark, A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer. ,vol. 94, pp. 97- 103 ,(2002) , 10.1002/CNCR.10202
J Carmichael, U Fink, RC Russell, MF Spittle, AL Harris, G Spiessi, J Blatter, Phase II study of gemcitabine in patients with advanced pancreatic cancer. British Journal of Cancer. ,vol. 73, pp. 101- 105 ,(1996) , 10.1038/BJC.1996.18
S Okada, , Y Sakata, S Matsuno, M Kurihara, Y Sasaki, Y Ohashi, T Taguchi, Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study British Journal of Cancer. ,vol. 80, pp. 438- 443 ,(1999) , 10.1038/SJ.BJC.6690375
P. Rougier, A. Adenis, M. Ducreux, M. de Forni, J. Bonneterre, M. Dembak, P. Clouet, A. Lebecq, P. Baille, F. Lefresne-Soulas, C. Blanc, J.P. Armand, A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma. European Journal of Cancer. ,vol. 36, pp. 1016- 1025 ,(2000) , 10.1016/S0959-8049(00)00072-1
A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, M. J. Thun, Cancer statistics, 2003. CA: A Cancer Journal for Clinicians. ,vol. 53, pp. 5- 26 ,(2003) , 10.3322/CANJCLIN.53.1.5
Renato Lenzi, Suayib Yalcin, Douglas B. Evans, James L. Abbruzzese, Phase II Study of Docetaxel in Patients with Pancreatic Cancer Previously Untreated with Cytotoxic Chemotherapy Cancer Investigation. ,vol. 20, pp. 464- 472 ,(2002) , 10.1081/CNV-120002146
Jordan D. Berlin, Paul Catalano, James P. Thomas, John W. Kugler, Daniel G. Haller, Al Bowen Benson, Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297 Journal of Clinical Oncology. ,vol. 20, pp. 3270- 3275 ,(2002) , 10.1200/JCO.2002.11.149
C Louvet, R Labianca, P Hammel, G Lledo, F De Braud, T Andre, M Cantore, M Ducreux, A Zaniboni, A De Gramont, None, GemOx (Gemcitabine + Oxaliplatin) versus Gem (Gemcitabine) in non resectable pancreatic adenocarcinoma : final results of the GERCOR /GISCAD Intergroup Phase III Journal of Clinical Oncology. ,vol. 22, pp. 4008- 4008 ,(2004) , 10.1200/JCO.2004.22.90140.4008